Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Prednisolone acetate |
Is a |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone sodium phosphate |
Is a |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone tertiary butylacetate |
Is a |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone adverse reaction |
Causative agent |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Topical prednisolone adverse reaction |
Causative agent |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Prednisolone drops adverse reaction |
Causative agent |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Rectal prednisolone preparations adverse reaction |
Causative agent |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Prednisolone measurement |
Has measured component |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone measurement |
Component |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
prednisolontebutatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Allergy to prednisolone |
Causative agent |
False |
Prednisolone |
Inferred relationship |
Some |
|
allergi over for prednisolon til topikal anvendelse |
Causative agent |
False |
Prednisolone |
Inferred relationship |
Some |
|
allergi over for prednisolondråber |
Causative agent |
False |
Prednisolone |
Inferred relationship |
Some |
|
allergi over for prednisolonpræparater til rektal anvendelse |
Causative agent |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone [for preparations see rectal prednisolone] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Rectal prednisolone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone 20mg/100mL enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 5 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 20 mg/100 ml retentionsklysma med langt rektalrør |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 20 mg/100 ml retentionsklysma med standardrektalrør |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Product containing precisely prednisolone 2.5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Product containing precisely prednisolone 5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 5 mg opløselig tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone sod phos [musc-sk] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone sod phos [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
prednisolon 20 mg rektalskum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
predinsolon til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolonnatriumphosphat 5 mg/5 ml flydende |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone sodium phosphate 6.7mg/5 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone sodium phosphat 20mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone ophthalmic preparation |
Is a |
False |
Prednisolone |
Inferred relationship |
Some |
|
Product containing prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
prednisolonnatriumphosphat +neomycinsulfat 0,5 %/0,5 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 0,001 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 0,003 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 0,01 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 0,01 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 0,03 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 0,03 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 0,1 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 0,1 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 0,3 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolon 0,3 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolondråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Product containing prednisolone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Prednisolone eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolonnatriumphosphat 20 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolonnatriumphosphat 20 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolonacetat 50 mg/ml injektionsvæske, suspension, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolonacetat 0,5 % wt/wt + sulfacetamidnatrium 10 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolonnatriumphosphat 20 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
prednisolonacetat 50 mg/ml injektionsvæske, suspension, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Serum prednisolone level (procedure) |
Component |
False |
Prednisolone |
Inferred relationship |
Some |
2 |
Prednisolone 20mg/100mL enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone 3 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Product containing cinchocaine and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
predinsolonhexanoat 1,3 mg + cinchocain suppositorium a 1 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Product containing neomycin and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 15 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone (as prednisolone sodium phosphate) 30 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone hexanoate (substance) |
Is a |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone methylsulfobenzoate |
Is a |
False |
Prednisolone |
Inferred relationship |
Some |
|
Allergy to prednisolone |
Causative agent |
False |
Prednisolone |
Inferred relationship |
Some |
2 |
allergi over for prednisolon til topikal anvendelse |
Causative agent |
False |
Prednisolone |
Inferred relationship |
Some |
1 |
allergi over for prednisolonpræparater til rektal anvendelse |
Causative agent |
False |
Prednisolone |
Inferred relationship |
Some |
1 |
allergi over for prednisolondråber |
Causative agent |
False |
Prednisolone |
Inferred relationship |
Some |
1 |
Allergy to prednisolone |
Causative agent |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Allergy to ophthalmic prednisolone |
Causative agent |
False |
Prednisolone |
Inferred relationship |
Some |
2 |
Prednisolone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
1 |
Prednisolone 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Prednisolone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
1 |
Prednisolone 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Prednisolone 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
1 |
Prednisolone 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Prednisolone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
1 |
Prednisolone 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Prednisolone caproate (substance) |
Is a |
False |
Prednisolone |
Inferred relationship |
Some |
|
Product containing gentamicin and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |
Prednisolone caproate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone hexanoate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone acetate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone sodium phosphate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone tertiary butylacetate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone methylsulfobenzoate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone 0.01% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone 0.03% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone 0.1% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Prednisolone 0.3% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prednisolone |
Inferred relationship |
Some |
|
Product containing precisely prednisolone 2.5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prednisolone |
Inferred relationship |
Some |
1 |